Stay updated on Nivolumab vs Dacarbazine in Melanoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab vs Dacarbazine in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab vs Dacarbazine in Melanoma Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Tel Litwinsky, Israel, 52621 was removed and Qiryat Krinitzi, Israel, 52621 was added to the study locations. Melanoma and MedlinePlus Genetics were added as related topics.
    Difference
    0.1%
    Check dated 2026-09-05T20:35:32.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.5 to v3.6.6, signaling a newer version of the page content.
    Difference
    0.0%
    Check dated 2026-08-29T20:02:46.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    Melanoma has been removed from the related topics section. The MedlinePlus Genetics link under related topics is also removed, and the related topics header is no longer displayed.
    Difference
    0.1%
    Check dated 2026-08-22T21:43:39.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    Footer/navigation blocks including BMS branding and sections such as 'BMS Clinical Trial Information' and 'BMS Clinical Trial Patient Recruiting' were added, along with related help links. Expanded MeSH term metadata and related topics were also included to enrich context and discoverability of the study.
    Difference
    82%
    Check dated 2026-08-15T20:49:52.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    The page’s revision tag was updated from v3.6.4 to v3.6.5, indicating a minor system or content update. This does not modify the study details or user-facing information.
    Difference
    0.0%
    Check dated 2026-08-08T18:29:07.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    The page now includes related topics entries for Melanoma and MedlinePlus Genetics. This enriches contextual links and indexing for discovery.
    Difference
    0.1%
    Check dated 2026-08-01T15:28:07.000Z thumbnail image

Stay in the know with updates to Nivolumab vs Dacarbazine in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab vs Dacarbazine in Melanoma Clinical Trial page.